You are here: Industry Insights > SARS-CoV-2

News List

Twist-Revelar’s therapy neutralises Omicron and Delta variants Pharmaceutical-Technology
January 07, 2022
Twist Bioscience and Revelar Biotherapeutics have reported data from live virus studies where their therapy, RBT-0813, showed it binds to and neutralises SARS-CoV-2 Omicron and Delta variants.
COVID-19 Oral Vaccine and Antibody Booster: B. subtilis Spores, Biotechnology Breakthrough by DreamTec prnasia
January 05, 2022
Vaccines have been a trending topic ever since the coronavirus outbreak two years ago. DreamTec Research Limited (DreamTec, http://www.dreamtec.hk) has its major breakthrough in developing a COVID-19 oral vaccine.
Ascletis Expands Ritonavir Oral Tablet Production and Announces Oral Direct-Acting Antiviral Pipeline Against SARS-CoV-2 Virus prnasia
January 04, 2022
Ascletis Pharma Inc. (HKEX: 1672) today announces the expansion of the production of ritonavir oral tablets and oral direct-acting antiviral R&D pipeline for the treatment of SARS-CoV-2 infection.
COVID-19 can trigger self-attacking antibodies WorldPharmaNews
January 04, 2022
Infection with the virus that causes COVID-19 can trigger an immune response that lasts well beyond the initial infection and recovery - even among people who had mild symptoms or no symptoms at all...
UK life sciences trade group calls for oral Covid-19 antiviral investment Pharmaceutical-Technology
January 04, 2022
The UK government must invest in Covid-19 antiviral treatments like it did with vaccines, said the chair of the UK BioIndustry Association.
Ascletis Expands Ritonavir Oral Tablet Production contractpharma
January 03, 2022
Also announces oral direct-acting antiviral pipeline against SARS-CoV-2 virus.
Merck and Ridgeback’s Molnupiravir Receives U.S. FDA Emergency Use Authorization for the Treatment of High-Risk Adults With Mild to Moderate COVID-19 Drugs
December 27, 2021
Merck (NYSE: MRK), known as MSD outside the United States and Canada, and Ridgeback Biotherapeutics today announced that the U.S. Food and Drug Administration (FDA) has granted Emergency Use Authorization...
HKU teams develop the first anti-COVID-19 stainless steel prnasia
December 23, 2021
The project team led by Professor Mingxin HUANG at the Department of Mechanical Engineering of the Faculty of Engineering of the University of Hong Kong, S.A.R., China (HKU)...
Humans Pass Coronavirus to Deer, Creating Reservoir for Variants drugs
December 23, 2021
In a sign that white-tailed deer are becoming a reservoir for the new coronavirus, researchers report that COVID-19 variants are spreading among the wild animals.
Antibody Response to SARS-CoV-2 Wanes Among Dialysis Patients Drugs
December 16, 2021
For persons receiving dialysis, the antibody response to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) wanes through five to six months and is associated with a risk for breakthrough infection...

Previous page 1 2 3 4 5 6 7 8 9 10 ... 61 62 Next page